190 related articles for article (PubMed ID: 17455969)
41. Protein pI shifts due to posttranslational modifications in the separation and characterization of proteins.
Zhu K; Zhao J; Lubman DM; Miller FR; Barder TJ
Anal Chem; 2005 May; 77(9):2745-55. PubMed ID: 15859589
[TBL] [Abstract][Full Text] [Related]
42. HMGA2: A pituitary tumour subtype-specific oncogene?
Fedele M; Palmieri D; Fusco A
Mol Cell Endocrinol; 2010 Sep; 326(1-2):19-24. PubMed ID: 20347930
[TBL] [Abstract][Full Text] [Related]
43. The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.
Tesfaye A; Di Cello F; Hillion J; Ronnett BM; Elbahloul O; Ashfaq R; Dhara S; Prochownik E; Tworkoski K; Reeves R; Roden R; Ellenson LH; Huso DL; Resar LM
Cancer Res; 2007 May; 67(9):3998-4004. PubMed ID: 17483309
[TBL] [Abstract][Full Text] [Related]
44. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
45. The characterization of protein post-translational modifications by mass spectrometry.
Schweppe RE; Haydon CE; Lewis TS; Resing KA; Ahn NG
Acc Chem Res; 2003 Jun; 36(6):453-61. PubMed ID: 12809532
[TBL] [Abstract][Full Text] [Related]
46. Ribosomal phosphoprotein P0 interacts with GCIP and overexpression of P0 is associated with cellular proliferation in breast and liver carcinoma cells.
Chang TW; Chen CC; Chen KY; Su JH; Chang JH; Chang MC
Oncogene; 2008 Jan; 27(3):332-8. PubMed ID: 17621266
[TBL] [Abstract][Full Text] [Related]
47. Identification of multiple post-translational modifications in the porcine brain specific p25alpha.
Kleinnijenhuis AJ; Hedegaard C; Lundvig D; Sundbye S; Issinger OG; Jensen ON; Jensen PH
J Neurochem; 2008 Jul; 106(2):925-33. PubMed ID: 18435830
[TBL] [Abstract][Full Text] [Related]
48. Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex.
Cho JY; Lee M; Ahn JM; Park ES; Cho JH; Lee SJ; Kim BG; Heo SH; Park HJ; Zerbini LF; Hwang D; Libermann TA
J Proteome Res; 2009 Mar; 8(3):1327-37. PubMed ID: 19203193
[TBL] [Abstract][Full Text] [Related]
49. Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation.
Kaddar T; Rouault JP; Chien WW; Chebel A; Gadoux M; Salles G; Ffrench M; Magaud JP
Biol Cell; 2009 Sep; 101(9):511-24. PubMed ID: 19250063
[TBL] [Abstract][Full Text] [Related]
50. Expression of high mobility group A proteins in oral leukoplakia.
Larsson L; Jäwert F; Magnusson B; Hasséus B; Kjeller G
Anticancer Res; 2013 Oct; 33(10):4261-6. PubMed ID: 24122990
[TBL] [Abstract][Full Text] [Related]
51. Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.
Sinchaikul S; Hongsachart P; Sriyam S; Tantipaiboonwong P; Phutrakul S; Chen ST
Chang Gung Med J; 2008; 31(5):417-30. PubMed ID: 19097588
[TBL] [Abstract][Full Text] [Related]
52. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
[TBL] [Abstract][Full Text] [Related]
53. Identification and characterization of human ARIP2 and its relation to breast cancer.
Li ZD; Wu Y; Bao YL; Yu CL; Guan LL; Wang YZ; Meng XY; Li YX
Cytokine; 2009 May; 46(2):251-9. PubMed ID: 19349195
[TBL] [Abstract][Full Text] [Related]
54. Global histone analysis by mass spectrometry reveals a high content of acetylated lysine residues in the malaria parasite Plasmodium falciparum.
Trelle MB; Salcedo-Amaya AM; Cohen AM; Stunnenberg HG; Jensen ON
J Proteome Res; 2009 Jul; 8(7):3439-50. PubMed ID: 19351122
[TBL] [Abstract][Full Text] [Related]
55. Identification of trimethylation at C-terminal lysine of pilin in the cyanobacterium Synechocystis PCC 6803.
Kim YH; Park KH; Kim SY; Ji ES; Kim JY; Lee SK; Yoo JS; Kim HS; Park YM
Biochem Biophys Res Commun; 2011 Jan; 404(2):587-92. PubMed ID: 21130745
[TBL] [Abstract][Full Text] [Related]
56. High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2.
Pierantoni GM; Rinaldo C; Mottolese M; Di Benedetto A; Esposito F; Soddu S; Fusco A
J Clin Invest; 2007 Mar; 117(3):693-702. PubMed ID: 17290307
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive identification of novel post-translational modifications in cellular peroxiredoxin 6.
Jeong J; Kim Y; Kyung Seong J; Lee KJ
Proteomics; 2012 May; 12(9):1452-62. PubMed ID: 22589192
[TBL] [Abstract][Full Text] [Related]
58. Alterations in the expression of PDCD4 in ductal carcinoma of the breast.
Wen YH; Shi X; Chiriboga L; Matsahashi S; Yee H; Afonja O
Oncol Rep; 2007 Dec; 18(6):1387-93. PubMed ID: 17982621
[TBL] [Abstract][Full Text] [Related]
59. Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array.
Radpour R; Kohler C; Haghighi MM; Fan AX; Holzgreve W; Zhong XY
Oncogene; 2009 Aug; 28(33):2969-78. PubMed ID: 19503099
[TBL] [Abstract][Full Text] [Related]
60. HMGA1 Overexpression is Associated With the Malignant Status and Progression of Breast Cancer.
Qi C; Cao J; Li M; Liang C; He Y; Li Y; Li J; Zheng X; Wang L; Wei B
Anat Rec (Hoboken); 2018 Jun; 301(6):1061-1067. PubMed ID: 29316384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
